IFI16 and osteosarcoma: Moreover, our ongoing studies with HSV-2 and HSV-1 with human osteosarcoma cells in which IFI16 is knocked out by CRISPR [6] demonstrate that in the absence of IFI16, the IFN-β response is significantly abrogated.